Sharing a great post: Celgene Reports More Good Crohn's Disease Data CELG

Celgene rolled out more upbeat data on its new Crohn's disease drug, sending the biotech giant's shares 3% higher on Tuesday.

http://ift.tt/1yrxbMK



via IFTTT